Stock COSMO PHARMACEUTICALS S.P.A
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Cosmo Pharmaceuticals S.p.A Swiss Exchange

Equities

IT0004167463

End-of-day quote Swiss Exchange
Other stock markets
- CHF - Intraday chart for Cosmo Pharmaceuticals S.p.A
Jun. 18 Switzerland's Cosmo Pharmaceuticals Receives Drug Registration Certificate for Lumeblue in China MT
Jun. 03 Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down MT

Chart calendar Cosmo Pharmaceuticals S.p.A

3c0a48f8808580b5b9e58e2e0a8.2kEBePYECjJfbwYnKrWYiBoGyDv3aLcdORU_VKvr-1c.sBt4Ta5HXkEPCkNgQf3x3EB-qkzPCs17fHJTFp3bjD6qGUg8rjRyRGwVaQ~e180de77a17662e913efd2ac3028f42b

Upcoming events on Cosmo Pharmaceuticals S.p.A

2024-07-04 Extraordinary Shareholders Meeting
2024-07-25 01:00 am Q2 2024 Earnings Release
2025-03-18 Q4 2024 Earnings Release (Projected)
2025-07-23 Q2 2025 Earnings Release (Projected)
2026-03-18 Q4 2025 Earnings Release (Projected)
2026-07-22 Q2 2026 Earnings Release (Projected)

Past events on Cosmo Pharmaceuticals S.p.A

2024-06-05 ODDO BHF Nextcap Forum
2024-05-24 06:00 am Annual General Meeting
2024-03-20 10:00 am Investor Day
2024-03-20 06:00 am Q4 2023 Earnings Call
2024-03-20 02:00 am Q4 2023 Earnings Release
2024-03-12 J.P. Morgan Pan-European Small/Mid-Cap CEO Conference
2024-01-15 ODDO BHF Forum
2023-12-04 CF&B Communication European Midcap Conference
2023-11-13 Jefferies London Healthcare Conference
2023-10-09 Investor Meeting - Day 2
2023-10-08 Investor Meeting - Day 1
2023-07-26 08:00 am Q2 2023 Earnings Call
2023-07-26 01:00 am Q2 2023 Earnings Release
2023-05-30 Détachement de for final dividend
2023-05-26 06:00 am Annual General Meeting
2023-03-27 Jefferies Pan-European Mid-Cap Conference
2023-03-23 Kepler Cheuvreux Swiss Seminar
2023-03-23 09:00 am Q4 2022 Earnings Call
2023-03-23 02:00 am Q4 2022 Earnings Release
2023-03-12 Berenberg EU Opportunities Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR		Released
Forecast
Spread 		62,5
47,1
32.64%		60,9
53,0
14.94%		65,1
62,4
4.3%		102
101
1.31%		96,7
139
-30.49%
264

EBITDA
Million EUR		Released
Forecast
Spread 		-6,55
-12,7
48.58%		12,9
9,31
38.99%		18,5
9,21
100.87%		41,9
39,4
6.34%		26,5
67,8
-60.94%
177

EBIT
Million EUR		Released
Forecast
Spread 		-12,3
-17,5
29.63%		6,91
3,31
108.93%		11,1
5,31
109.26%		28,1
28,7
-2.33%		12,2
56,3
-78.29%
162

Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread 		-21,3
-28,8
26.11%		-6,93
-7,45
6.97%		24,0
21,0
14.3%		24,5
23,7
3.19%		7,61
63,3
-87.97%
163

Net income
Million EUR		Released
Forecast
Spread 		-24,5
-27,6
11.25%		-7,90
-6,47
-22.12%		21,7
11,3
91.37%		17,2
21,4
-19.57%		1,15
34,5
-96.67%
124

EPS
EUR		Released
Forecast
Spread 		-1,67
-1,83
8.71%		-0,55
-0,43
-27.57%		1,29
0,72
77.89%		1,05
1,12
-6%		0,07
0,72
-90.07%
7,67

Announcement Date03/04/2026/03/2123/03/2223/03/2320/03/24-

Quarterly results

Fiscal PeriodDecember 2019 S2 2020 S1 2021 S1 2022 S1 2022 S2 2023 S1 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2
Net sales
Million EUR		Released
Forecast
Spread 		41,0
23,3
75.91%		25,9
22,1
17.38%		28,4
27,9
2.05%		41,5
38,7
7.26%		60,6
58,0
4.44%		43,7
44,6
-2.11%
132


37,3


143


44,3


51,8


114

EBITDA
Million EUR		Released
Forecast
Spread 		8,04
3,70
117.32%
































EBIT
Million EUR		Released
Forecast
Spread 		4,89
-0,90
643.78%		2,66
-4,20
163.38%		0,01
0,55
-98.55%		8,11
3,20
153.38%		19,9
19,5
2.3%		7,12
4,90
45.37%
108


12,0


94,6


17,4


23,3


66,9

Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread 		1,32
-8,00
116.44%		-5,33
-8,45
36.91%		-4,67
-6,45
27.64%		9,09
-1,10
926.27%		15,4
15,6
-1.38%		3,67
1,30
182.54%






95,0








67,5

Net income
Million EUR		Released
Forecast
Spread 		-3,71
-6,55
43.33%		-3,02
-8,45
64.32%		-5,74
-6,45
10.99%		7,90
-1,10
817.82%		9,33
14,8
-36.97%		1,49
1,00
48.6%






68,4








48,6

EPS
EUR		Released
Forecast
Spread 		-0,26
-0,50
47.6%		-0,21
-0,55
61.9%		-0,40
-0,43
6.12%		0,48
-0,06
893.33%		0,57
0,90
-36.33%		0,09
0,06
53.33%






4,26








3,02

Announcement Date03/04/2030/07/2030/07/2128/07/2223/03/2326/07/23------

Upcoming sector events for Cosmo Pharmaceuticals S.p.A

2024-07-03 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
2024-07-10 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
2024-07-15 CAMURUS AB: Q2 2024 Earnings Release
2024-07-16 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-17 06:45 am JOHNSON & JOHNSON: Q2 2024 Earnings Release
2024-07-17 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-18 01:00 am NOVARTIS AG: Q2 2024 Earnings Release
2024-07-21 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-21 ALMIRALL, S.A.: Q2 2024 Earnings Release
2024-07-22 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Cosmo Pharmaceuticals S.p.A

2024-06-21 11:28 am DEVA HOLDING: Q1 2024 Earnings Release
2024-06-13 05:21 pm EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
2024-06-11 01:30 am BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release
2024-06-07 06:33 am SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release
2024-06-07 05:17 am LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release
2024-05-30 08:08 am SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-30 07:00 am ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
2024-05-30 02:24 am MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-29 08:00 am FDC LIMITED: Q4 2024 Earnings Release
2024-05-29 05:26 am JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. COPN Stock
  4. Stock
  5. Calendar Cosmo Pharmaceuticals S.p.A